Dr. Reddy's Laboratories Ltd. closed 18.62% short of its 52-week high of 1,420.20 rupees, which the company reached on August 21st.

Dr. Reddy's Laboratories Ltd. closed 21.90% short of its 52-week high of 1,420.20 rupees, which the company reached on August ...

Dr. Reddy’s (RDY) commented on a news item published in Business Standard on April 13, with the heading “DRL trims workforce costs by 25% amid ...

At close: April 11 at 3:30:00 PM GMT+5:30 ...

Dr Reddy’s, one of India's leading drug manufacturers and suppliers ... Among these, the Integrated Product Development Organisation in Bachupally, Telangana is the most significant centre featuring ...

Bonus Apr 08, 1994 May 03, 1994 Mar 24, 1994 Bonus Ratio: 2 share(s) for every 1 shares held Bonus Dec 04, 1992 Dec 22, 1992 Sep 30, 1992 Bonus Ratio: 1 share(s) for every 1 shares held Dr. Reddy's ...

Dr. Reddy's Laboratories is among India’s leading pharmaceutical companies. The company is primarily known for manufacturing active pharmaceutical ingredients (APIs). Dr. Reddy's Laboratories ...

Sanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, though a licensing agreement remains a possibility. The asking price has ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Dr. Reddy's Laboratories Ltd. is a Public Limited Listed company incorporated on 24/02/1984 and has its registered office in the State of Telangana, India. Company's Corporate Identification ...